Next Article in Journal
Molecular Epidemiology of SARS-CoV-2: The Dominant Role of Arginine in Mutations and Infectivity
Next Article in Special Issue
The Outcome of BNT162b2, ChAdOx1-Sand mRNA-1273 Vaccines and Two Boosters: A Prospective Longitudinal Real-World Study
Previous Article in Journal
A Spontaneously Occurring African Swine Fever Virus with 11 Gene Deletions Partially Protects Pigs Challenged with the Parental Strain
Previous Article in Special Issue
Electrostatic Surface Potential as a Key Parameter in Virus Transmission and Evolution: How to Manage Future Virus Pandemics in the Post-COVID-19 Era
 
 
viruses-logo
Article Menu

Article Menu

Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Omicron Waves in Argentina: Dynamics of SARS-CoV-2 Lineages BA.1, BA.2 and the Emerging BA.2.12.1 and BA.4/BA.5

by
Carolina Torres
1,2,*,
Mercedes Nabaes Jodar
2,3,
Dolores Acuña
2,3,
Romina Micaela Zambrana Montaño
1,2,
Andrés Carlos Alberto Culasso
1,2,
Ariel Fernando Amadio
2,4,
Paula Aulicino
2,5,
Santiago Ceballos
6,
Marco Cacciabue
7,
Humberto Debat
8,
María José Dus Santos
9,10,
María Florencia Eberhardt
2,4,
Carlos Espul
11,
Fabián Fay
12,
María Ailén Fernández
13,
Franco Fernández
8,
Juan Manuel Fernandez Muñoz
14,
Florencia Ferrini
15,
Fernando Gallego
6,
Adriana Angélica Giri
16,
Agustina Cerri
16,
Elisa Bolatti
16,
María Ines Gismondi
7,17,
Stephanie Goya
3,
Iván Gramundi
6,
José Matías Irazoqui
2,4,
Guido Alberto König
7,
Viviana Leiva
11,
Horacio Lucero
18,
Nathalie Marquez
8,
Cristina Nardi
6,
Belén Ortiz
11,
Luis Pianciola
13,
Carolina Beatriz Pintos
13,
Andrea Fabiana Puebla
7,
Carolina Victoria Rastellini
13,
Alejandro Ezequiel Rojas
6,
Javier Sfalcin
12,
Ariel Suárez
19,
Estefanía Tittarelli
19,
Rosana Toro
20,
Gabriela Vanina Villanova
2,21,
María Cecilia Ziehm
13,
María Carla Zimmermann
15,
Sebastián Zunino
17,22,
Proyecto PAIS Working Group
23,†,
Laura Valinotto
2,3 and
Mariana Viegas
2,3,*
add Show full author list remove Hide full author list
1
Instituto de Investigaciones en Bacteriología y Virología Molecular (IbaViM), Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Ciudad Autónoma de Buenos Aires 1113, Argentina
2
Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Ciudad Autónoma de Buenos Aires 1425, Argentina
3
Laboratorio de Virología Hospital de Niños Dr. Ricardo Gutiérrez, Ciudad Autónoma de Buenos Aires 1425, Argentina
4
Instituto de Investigación de la Cadena Láctea (IDICAL) INTA-CONICET, Rafaela 2300, Argentina
5
Laboratorio de Biología Celular y Retrovirus, Hospital de Pediatría “Prof. Juan P. Garrahan”, Ciudad Autónoma de Buenos Aires 1245, Argentina
6
Hospital Regional Ushuaia; Universidad Nacional de Tierra del Fuego, Antártida e Islas del Atlántico Sur, UNTDF y CADIC-CONICET, Ushuaia 9410, Argentina
7
Instituto de Biotecnología/Instituto de Agrobiotecnología y Biología Molecular (INTA-CONICET), Hurlingham 1686, Argentina
8
Instituto de Patología Vegetal-Centro de Investigaciones Agropecuarias Instituto Nacional de Tecnología Agropecuaria (IPAVE-CIAP-INTA), Córdoba 5020, Argentina
9
Instituto de Virología e Innovaciones Tecnológicas (INTA-CONICET), Hurlingham 1686, Argentina
10
Laboratorio de Diagnóstico-UNIDAD COVID- Universidad Nacional de Hurlingham, Hurlingham 1688, Argentina
11
Laboratorio de Salud Pública, Godoy Cruz 5501, Argentina
12
CIBIC Laboratorio, Rosario 2000, Argentina
13
Laboratorio Central Neuquén, Ministerio de Salud de la Provincia del Neuquén, Neuquén 8302, Argentina
14
Instituto de Medicina y Biología Experimental de Cuyo (IMBECU—CONICET), Mendoza 5500, Argentina
15
Laboratorio de Medicina Genómica, Facultad de Medicina, Universidad Nacional del Nordeste, Corrientes 3400, Argentina
16
IBR-CONICET, Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario, Rosario 2000, Argentina
17
Departamento de Ciencias Básicas, Universidad Nacional de Luján, Luján 6700, Argentina
18
Instituto de Medicina Regional, Resistencia 3500, Argentina
19
Departamento de Biología y Genética Molecular, IACA Laboratorios, Bahía Blanca 8000, Argentina
20
Laboratorio de salud pública, Facultad de Ciencias Exactas, UNLP, La Plata 1900, Argentina
21
Laboratorio de Biotecnología Acuática, Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario, Centro Científico Tecnológico y Educativo Acuario del río Paraná, Rosario 2000, Argentina
22
Laboratorio de Virología Molecular, Hospital Blas L. Dubarry, Mercedes 6600, Argentina
23
PAIS Working Group, Ministerio de Ciencia Tecnología e Innovación, Ciudad Autónoma de Buenos Aires 1425, Argentina
*
Authors to whom correspondence should be addressed.
PAIS Working Group at http://pais.qb.fcen.uba.ar/about.php.
Viruses 2023, 15(2), 312; https://doi.org/10.3390/v15020312
Submission received: 30 December 2022 / Revised: 14 January 2023 / Accepted: 18 January 2023 / Published: 22 January 2023

Abstract

The COVID-19 pandemic has lately been driven by Omicron. This work aimed to study the dynamics of SARS-CoV-2 Omicron lineages during the third and fourth waves of COVID-19 in Argentina. Molecular surveillance was performed on 3431 samples from Argentina, between EW44/2021 and EW31/2022. Sequencing, phylogenetic and phylodynamic analyses were performed. A differential dynamic between the Omicron waves was found. The third wave was associated with lineage BA.1, characterized by a high number of cases, very fast displacement of Delta, doubling times of 3.3 days and a low level of lineage diversity and clustering. In contrast, the fourth wave was longer but associated with a lower number of cases, initially caused by BA.2, and later by BA.4/BA.5, with doubling times of about 10 days. Several BA.2 and BA.4/BA.5 sublineages and introductions were detected, although very few clusters with a constrained geographical distribution were observed, suggesting limited transmission chains. The differential dynamic could be due to waning immunity and an increase in population gatherings in the BA.1 wave, and a boosted population (for vaccination or recent prior immunity for BA.1 infection) in the wave caused by BA2/BA.4/BA.5, which may have limited the establishment of the new lineages.
Keywords: SARS-CoV-2; Omicron; variants; evolution; South America; dynamics; BA.1; BA.2; BA.4; BA.5 SARS-CoV-2; Omicron; variants; evolution; South America; dynamics; BA.1; BA.2; BA.4; BA.5

Share and Cite

MDPI and ACS Style

Torres, C.; Nabaes Jodar, M.; Acuña, D.; Montaño, R.M.Z.; Culasso, A.C.A.; Amadio, A.F.; Aulicino, P.; Ceballos, S.; Cacciabue, M.; Debat, H.; et al. Omicron Waves in Argentina: Dynamics of SARS-CoV-2 Lineages BA.1, BA.2 and the Emerging BA.2.12.1 and BA.4/BA.5. Viruses 2023, 15, 312. https://doi.org/10.3390/v15020312

AMA Style

Torres C, Nabaes Jodar M, Acuña D, Montaño RMZ, Culasso ACA, Amadio AF, Aulicino P, Ceballos S, Cacciabue M, Debat H, et al. Omicron Waves in Argentina: Dynamics of SARS-CoV-2 Lineages BA.1, BA.2 and the Emerging BA.2.12.1 and BA.4/BA.5. Viruses. 2023; 15(2):312. https://doi.org/10.3390/v15020312

Chicago/Turabian Style

Torres, Carolina, Mercedes Nabaes Jodar, Dolores Acuña, Romina Micaela Zambrana Montaño, Andrés Carlos Alberto Culasso, Ariel Fernando Amadio, Paula Aulicino, Santiago Ceballos, Marco Cacciabue, Humberto Debat, and et al. 2023. "Omicron Waves in Argentina: Dynamics of SARS-CoV-2 Lineages BA.1, BA.2 and the Emerging BA.2.12.1 and BA.4/BA.5" Viruses 15, no. 2: 312. https://doi.org/10.3390/v15020312

APA Style

Torres, C., Nabaes Jodar, M., Acuña, D., Montaño, R. M. Z., Culasso, A. C. A., Amadio, A. F., Aulicino, P., Ceballos, S., Cacciabue, M., Debat, H., Dus Santos, M. J., Eberhardt, M. F., Espul, C., Fay, F., Fernández, M. A., Fernández, F., Muñoz, J. M. F., Ferrini, F., Gallego, F., ... Viegas, M. (2023). Omicron Waves in Argentina: Dynamics of SARS-CoV-2 Lineages BA.1, BA.2 and the Emerging BA.2.12.1 and BA.4/BA.5. Viruses, 15(2), 312. https://doi.org/10.3390/v15020312

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop